Wholesale of pharmaceutical and medical goods
ZIMMER BIOMET NORWAY AS
Revenue 2024
NOK 161.7m
Operating profit
NOK 10.2m
Equity
NOK 36.9m
Incorporated
2010
Employees
10
Share capital
NOK 200,000
Key figures · 2024
Current ratio
1.67
Equity ratio
59.9%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 6.3% | |
| Net margin (%%) | 5.4% | |
| Return on assets (%%) | 16.6% | |
| Likviditet | ||
| Current ratio | 1.67 | |
| Working capital | 16.4m | |
| Soliditet | ||
| Equity ratio (%%) | 59.9% | |
| Debt-to-equity ratio | 0.67 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.